Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.23
Delayed Data
As of Dec 02
 +0.01 / +0.02%
Today’s Change
31.25
Today|||52-Week Range
57.82
-23.58%
Year-to-Date
Ready to Get In on Biotech? Check Out These 3 Stocks
Nov 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close43.22
Today’s open43.14
Day’s range42.47 - 44.22
Volume977,242
Average volume (3 months)822,257
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-59.65%
Earnings growth (next 5 years)-36.43%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book8.79

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-0.47-0.44%
XONIntrexon Corp+0.44+1.58%
BLUEbluebird bio Inc+1.10+1.60%
ARIAARIAD Pharmaceutical...+0.09+0.69%
Data as of 4:14pm ET, 12/02/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs